What is the dosage of Xolair?

Xolair is available in 7 dosages, including 150 mg Injection, 150 mg/ml Auto-Injector 0.5 ml, 150 mg/ml Prefilled Syringe 1 ml, 150 mg/ml Auto-Injector 1 ml, 150 mg/ml Auto-Injector 2 ml, 150 mg/ml Prefilled Syringe 2 ml and 150 mg/ml Prefilled Syringe 0.5 ml

What is Xolair mechanism of action?

Xolair mechanism of action is IgE-directed Antibody Interactions

Xolair Prescribing & Dosing Schedule

Q: What is Xolair made of?

Xolair contains omalizumab which is a Anti-IgE

Q: How is Xolair administered?

Xolair is administered as a Injectable

Dosage & Administration

For subcutaneous (SC) administration only.

See full prescribing information for administration instructions .

* Asthma: XOLAIR 75 to 375 mg SC every 2 or 4 weeks. Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL), measured before the start of treatment, and body weight (kg). See the dose determination charts.
* Chronic Rhinosinusitis with Nasal Polyps: XOLAIR 75 to 600 mg SC every 2 or 4 weeks. Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL), measured before the start of treatment, and body weight (kg). See the dose determination charts.
* IgE-Mediated Food Allergy: XOLAIR 75 mg to 600 mg SC every 2 or 4 weeks. Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL), measured before the start of treatment, and body weight (kg). See the dose determination chart.
* Chronic Spontaneous Urticaria: XOLAIR 150 or 300 mg SC every 4 weeks. Dosing in CSU is not dependent on serum IgE level or body weight.

Get Your Patient on Xolair

Find restrictionsSee step therapiesCompare coverage options

Xolair Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Request Xolair Samples

Online Sample Form

Learn More

Xolair Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Appeals

Complete Letter of Medical Necessity

Benefits investigation

Patient Consent Form - English

Patient Consent Form - Spanish

Prescriber Service Form - Online Portal

Xolair Prescriber Service Form

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Xolair Preferred Pharmacy

Pharmacy List

Xolair Financial Assistance Options

Copay savings program

Xolair Prescriber Service Form

Patient Consent Form - English

Patient Consent Form - Spanish

Prescriber Service Form - Online Portal

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

Xolair Prescriber Service Form

Patient Consent Form - English

Patient Consent Form - Spanish

Prescriber Service Form - Online Portal

Genentech Patient Assistance Foundation Application: Prescriber Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.